|
|
|
Corporate Profile: Oncothyreon
| Summary: |
Oncothyreon is focused on the research, development, and commercialization of vaccines and small molecules to treat a variety of cancer indications.
|
| Address (HQ): |
2601 Fourth Avenue
Suite 500
Seattle, WA 98121 |
| Phone #'s (HQ): |
| Main |
(206) 801-2100 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax #'s (HQ): |
| Main |
(206) 801-2101 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| ONTY |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
